Kailera Therapeutics, Inc. (KLRA): 8-K filed May 26, 2026

Form type

8-K

Filing date

May 26, 2026

Accession number

0001193125-26-239362

Filer

Kailera Therapeutics, Inc. (CIK 2096997)